CD274 and neoplasm: While MMR IHC serves as a proxy for predicting checkpoint inhibitor response by genomic instability, IHC is also used directly on tumour-expressed Programmed Death Ligand-1 (PD-L1), which binds to the immune cell receptor PD-1 [39,59,84,96].